Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$209.01 - $232.56 $6.71 Million - $7.46 Million
32,083 Added 148.24%
53,725 $11.7 Million
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $535,344 - $615,501
2,708 Added 14.3%
21,642 $4.92 Million
Q3 2023

Nov 13, 2023

BUY
$201.05 - $221.7 $20,708 - $22,835
103 Added 0.55%
18,934 $3.81 Million
Q2 2023

Aug 08, 2023

SELL
$211.93 - $241.33 $3.6 Million - $4.1 Million
-16,979 Reduced 47.41%
18,831 $4.54 Million
Q1 2023

May 12, 2023

SELL
$213.32 - $257.83 $2.81 Million - $3.4 Million
-13,196 Reduced 26.93%
35,810 $8.22 Million
Q4 2022

Feb 13, 2023

SELL
$203.72 - $248.97 $1.71 Million - $2.09 Million
-8,405 Reduced 14.64%
49,006 $11.5 Million
Q3 2022

Nov 10, 2022

BUY
$204.81 - $262.19 $2.84 Million - $3.63 Million
13,844 Added 31.78%
57,411 $11.8 Million
Q2 2022

Aug 03, 2022

SELL
$213.86 - $277.87 $3.9 Million - $5.07 Million
-18,257 Reduced 29.53%
43,567 $10.2 Million
Q1 2022

May 13, 2022

BUY
$259.82 - $298.18 $1.64 Million - $1.88 Million
6,320 Added 11.39%
61,824 $16.3 Million
Q4 2021

Feb 10, 2022

BUY
$271.6 - $314.21 $1.03 Million - $1.2 Million
3,809 Added 7.37%
55,504 $17.4 Million
Q3 2021

Nov 09, 2021

BUY
$274.82 - $308.34 $1.8 Million - $2.02 Million
6,550 Added 14.51%
51,695 $14.5 Million
Q2 2021

Jul 20, 2021

SELL
$251.87 - $278.14 $41.6 Million - $45.9 Million
-165,101 Reduced 78.53%
45,145 $12.5 Million
Q1 2021

Apr 29, 2021

SELL
$204.88 - $255.03 $1,024 - $1,275
-5 Reduced -0.0%
210,246 $41.1 Million
Q4 2020

Jan 22, 2021

SELL
$186.91 - $214.42 $1.48 Million - $1.69 Million
-7,905 Reduced 3.62%
210,251 $42.8 Million
Q3 2020

Oct 19, 2020

BUY
$167.03 - $201.3 $1.74 Million - $2.1 Million
10,437 Added 5.02%
218,156 $41.1 Million
Q2 2020

Jul 23, 2020

BUY
$113.31 - $182.44 $10.3 Million - $16.6 Million
90,931 Added 77.86%
207,719 $34.5 Million
Q1 2020

May 26, 2020

BUY
$104.32 - $195.28 $1,564 - $2,929
15 Added 0.01%
116,788 $19.3 Million
Q4 2019

Jan 21, 2020

BUY
$163.48 - $173.61 $1.96 Million - $2.09 Million
12,015 Added 11.47%
116,773 $20,000
Q3 2019

Oct 21, 2019

SELL
$159.77 - $178.1 $428,183 - $477,308
-2,680 Reduced 2.49%
104,758 $18,000
Q2 2019

Aug 01, 2019

BUY
$144.16 - $172.9 $1.51 Million - $1.81 Million
10,485 Added 10.81%
107,438 $18.5 Million
Q1 2019

May 02, 2019

BUY
$123.7 - $156.3 $9.03 Million - $11.4 Million
73,004 Added 304.83%
96,953 $14.8 Million
Q4 2018

Feb 14, 2019

BUY
$120.82 - $174.09 $92,306 - $133,004
764 Added 3.3%
23,949 $3.03 Million
Q3 2018

Nov 07, 2018

SELL
$167.67 - $188.27 $697,004 - $782,638
-4,157 Reduced 15.2%
23,185 $4.03 Million
Q2 2018

Aug 14, 2018

SELL
$160.33 - $189.41 $2,404 - $2,841
-15 Reduced 0.05%
27,342 $4.91 Million
Q1 2018

May 09, 2018

BUY
$161.53 - $178.11 $760,483 - $838,541
4,708 Added 20.79%
27,357 $4.43 Million
Q4 2017

Feb 07, 2018

SELL
$147.99 - $163.95 $111,732 - $123,782
-755 Reduced 3.23%
22,649 $3.61 Million
Q3 2017

Nov 03, 2017

BUY
$149.47 - $160.56 $3.5 Million - $3.76 Million
23,404
23,404 $3.53 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.